Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
HER2-PREDICT: Translational Study of Tumor Samples From Patients Treated With Trastuzumab Deruxtecan (T-DXd; DS-8201a)Neoplasm Metastasis, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, metastatic malignant neoplasm, neoplasmActive, not recruitingNot applicable2025-09-09NCT04257162

2 results · Page 1 of 1

Swipe the table sideways for more columns.

15 results · Page 1 of 1

Swipe the table sideways for more columns.